| |
| |
Immunotherapy of Human Neoplasms with Autologous Lymphocytes Activated In-Vitro. |
 | | With the recognition of the immunologic role of the lymphocyte, it became possible to envision such lymphocytic infiltration as a host immunologic response to the neoplastic cells, in a pattern similar to that seen in the homograft rejection reaction (Murphy, 1926). |
 | | Lymphocyte immunity against neoplasms appears to be mediated by lymphocytes which are thymus-dependent (Miller and Osoba, 1967), and such lymphocytes are preferentially activated by phytohemagglutinin (Davies, et al, 1968; Greaves, et al, 1968). |
 | | During the course of in-vitro lymphocyte activation, the highly-purified glycoprotein octamer of phytohemagglutinin penetrates into the nucleus of the lymphocytes and is bound preferentially to hetrochromatin complexes (Stanley, et al, 1968, 1970), where it effects a conversion of heterochromatin to active euchromatin (Tokuyasu, et al, 1968). |
| www.euchromatin.net /Immune1.htm (3940 words) |
|